Recombinant blaNDM-1 Protein

Katalog-Nummer 230-00554-50

Size : 50ug

Marke : RayBiotech


Recombinant blaNDM-1 Protein

Recombinant bacterial blaNDM-1 protein derived from E.coli
Contact Us for Bulk Request

Product Description

Specifications

Size10 µg, 100 µg
SpeciesE. coli
Accession Number
E5KIY2
Gene Symbols
BLANDM-1
Protein Name / Synonyms
New Delhi metallo-beta-lactamase-1, blaNDM-1
Expressed Region
Gly29-Arg270
Expression SystemE. coli
TagN-terminal 6x histidine tag
Purity
> 95%
Purity Determined BySDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Molecular Weight (kDa)
27.9 kDa
Format
Liquid
Formulation
Supplied as a 0.2 µm filtered solution in PBS.
Concentration (lot specific)
Lot specific (see the label on the vial)
Preservative
None
Endotoxin LevelNot determined
Research AreaAntimicrobial Resistance
Shipping TypeBlue ice
Storage-20°C
SDS-PAGE Image
Activity
Measured by its binding ability in a functional ELISA. Immobilized recombinant blaNDM-1 (Code: 230-00554) can bind rabbit anti-blaNDM-1 antibody with EC50 at 21.8 ng/mL.
Activity Image


Measured by its ability to hydrolyze Nitrocefin. The specific activity is >4,000 nmol/min/mg.
Activity Image
Storage/Stability
Upon arrival, the protein may be stored for 2 weeks at 4°C. For long term storage, it is recommended to store at -20°C or -80°C in appropriate aliquots. Avoid repeated freeze-thaw cycles.

Introduction

New Delhi Metallo-β-Lactamase-1 (NDM-1) is an enzyme produced by certain bacterial strains, conferring resistance to a broad spectrum of β-lactam antibiotics, including carbapenems, which are often considered antibiotics of last resort. NDM-1's ability to hydrolyze these antibiotics poses significant challenges in treating bacterial infections, leading to limited therapeutic options and increased mortality rates. The gene encoding NDM-1 is often located on plasmids, facilitating its rapid dissemination among various bacterial species and contributing to the global spread of multidrug-resistant pathogens.

Reference: https://pubmed.ncbi.nlm.nih.gov/30700432/

citations

  • Potentiation of Antibiotic Activity of Aztreonam against Metallo-β-Lactamase-Producing Multidrug-Resistant Pseudomonas aeruginosa by 3-O-Substituted Difluoroquercetin Derivatives

    Sample Type:
    Purified / Recombinant Protein (recombinant enzyme for β-lactamase inhibition assay)
    Year:
    2024
    Journal Name:
    Pharmaceutics
    PubMed ID:
    38399246
  • 7-O-Carboxylic Acid-Substituted 3-O-Alkyl Difluoroquercetin; An Aztreonam-Potentiating Agent Against Carbapenemase-Producing Pseudomonas aeruginosa Through Simultaneous Inhibition of Metallo-β-Lactamase and Efflux Pump

    Sample Type:
    Other / Unspecified (β-lactamase inhibition assay)
    Year:
    2024
    Journal Name:
    Antibiotics (Basel, Switzerland)
    PubMed ID:
    39766592
  • In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales

    Year:
    2023
    Journal Name:
    ACS Infectious Diseases
  • In Silico and In Vitro Screening of Natural Compounds as Broad-Spectrum β-Lactamase Inhibitors against Acinetobacter baumannii New Delhi Metallo-β-lactamase-1 (NDM-1)

    Year:
    2022
    Journal Name:
    Biomed Research International
    PubMed ID:
    35372567

Sie könnten auch an folgenden Produkten interessiert sein:



Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
230-00554-10
 10ug 
230-00554-500
 500ug